|
CTBP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.689990E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.718400E-01 |
| Normal-vs-Stage2 |
4.837000E-01 |
| Normal-vs-Stage3 |
1.674460E-02 |
| Normal-vs-Stage4 |
5.878400E-03 |
| Stage1-vs-Stage2 |
2.539800E-01 |
| Stage1-vs-Stage3 |
4.804400E-02 |
| Stage1-vs-Stage4 |
1.471910E-02 |
| Stage2-vs-Stage3 |
2.922100E-02 |
| Stage2-vs-Stage4 |
8.722900E-03 |
| Stage3-vs-Stage4 |
3.492200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.332830E-01 |
| Normal-vs-AfricanAmerican |
6.182200E-01 |
| Normal-vs-Asian |
2.154200E-01 |
| Caucasian-vs-AfricanAmerican |
8.071000E-01 |
| Caucasian-vs-Asian |
8.025600E-01 |
| AfricanAmerican-vs-Asian |
6.888400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.276000E-01 |
| Normal-vs-Female |
1.698840E-01 |
| Male-vs-Female |
8.466200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.200400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.826420E-01 |
| Normal-vs-Age(61-80Yrs) |
2.308800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.832400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.542000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.449800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.747200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.762400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.187000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.050600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.93489999999308E-05 |
| Classical-VS-Follicular |
7.692200E-01 |
| Classical-VS-Other |
9.257000E-01 |
| Classical-VS-Normal |
4.608600E-01 |
| Tall-VS-Follicular |
1.771810E-04 |
| Tall-VS-Other |
1.716980E-01 |
| Tall-VS-Normal |
3.67110000000226E-05 |
| Follicular-VS-Other |
9.980000E-01 |
| Follicular-VS-Normal |
7.446800E-01 |
| Other-VS-Normal |
9.118800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.021600E-01 |
| Normal-vs-N1 |
3.786300E-02 |
| N0-vs-N1 |
1.046790E-01 |
|
|
